mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.05 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.05 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.05 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.05 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.094 |
0.06 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |